Callan JMB Inc. (CJMB) Key Metrics
CJMB valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $14.6M
- Enterprise value
- $15.4M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 2.9
- Price / book
- 20.7
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- —
CJMB key metrics, 2022–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCJMB returns How much profit the business earns on the capital it uses.
CJMB per-share figures Results divided by the shares outstanding at year-end.
CJMB financial health Debt, liquidity and how easily interest is covered.
CJMB efficiency & capital use Working capital cycle and where the cash goes.
CJMB valuation history
CJMB returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CJMB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CJMB cash returned to shareholders
CJMB price vs earnings per share
CJMB key metrics
2022–2025| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Valuation | ||||
| Market capitalization | $4.9M | — | — | — |
| Enterprise value | $4.7M | — | — | — |
| Price / sales | 0.8 | — | — | — |
| Price / book | 2.1 | — | — | — |
| EV / sales | 0.8 | — | — | — |
| Earnings yield | −163.9% | — | — | — |
| Free cash flow yield | −106.2% | — | — | — |
| Dividend yield | 0.0% | — | — | — |
| Shareholder yield (dividends + buybacks) | 0.0% | — | — | — |
| Share price at fiscal year-end | $1.11 | — | — | — |
| Per share | ||||
| Revenue per share | $1.31 | $1.10 | $2.64 | $4.55 |
| Earnings per share | −$1.82 | −$0.38 | $0.44 | $1.24 |
| Operating cash flow per share | −$1.04 | $0.09 | $1.40 | $1.87 |
| Free cash flow per share | −$1.18 | $0.08 | $1.30 | $1.79 |
| Cash per share | $0.49 | $0.35 | $1.03 | $1.24 |
| Book value per share | $0.53 | $0.53 | $1.76 | $2.80 |
| Tangible book value per share | $0.53 | $0.53 | $1.76 | $2.80 |
| Dividends per share | $0.00 | $0.56 | $1.48 | $0.89 |
| Capex per share | $0.14 | $0.01 | $0.10 | $0.08 |
| Debt per share | $0.46 | $0.15 | $0.08 | $0.08 |
| Shares outstanding | 4.4M | 6.0M | 5.0M | 5.0M |
| Change in shares outstanding | −26.7% | +19.6% | −0.0% | — |
| Returns & profitability | ||||
| Return on equity (ROE) | −289.6% | −38.3% | 19.1% | 44.4% |
| Return on invested capital (ROIC) | −245.3% | −59.7% | 35.5% | 75.6% |
| Return on assets (ROA) | −146.7% | −31.0% | 17.5% | 40.8% |
| Return on tangible assets | −137.9% | −45.1% | 22.5% | 40.8% |
| Free cash flow margin | −90.2% | 7.5% | 49.3% | 39.3% |
| Income quality (OCF / net income) | — | — | 3.21 | 1.51 |
| Financial health | ||||
| Total debt | $2.0M | $907,450 | $399,997 | $410,885 |
| Cash & short-term investments | $2.1M | $2.1M | $5.2M | $6.2M |
| Net debt | −$129,246 | −$1.2M | −$4.8M | −$5.8M |
| Debt / equity | 0.86 | 0.29 | 0.05 | 0.03 |
| Debt / assets | 0.35 | 0.18 | 0.04 | 0.03 |
| Net debt / EBITDA | — | — | −2.06 | −0.91 |
| Current ratio | 2.16 | 2.59 | 10.98 | 12.94 |
| Quick ratio | 1.99 | 2.47 | 10.83 | 12.87 |
| Interest coverage | — | -423.5 | 270.8 | — |
| Working capital | $1.6M | $2.0M | $7.7M | $13.3M |
| Invested capital | $2.2M | $2.0M | $4.0M | $8.2M |
| Tangible asset value | $2.3M | $3.2M | $8.8M | $14.0M |
| Net current asset value | −$389,062 | $1.4M | $7.5M | $13.1M |
| Graham number | — | — | $4.16 | $8.86 |
| Graham net-net per share | −$0.21 | $0.13 | $1.30 | $2.18 |
| Capital allocation | ||||
| Dividends paid | $0 | $3.3M | $7.4M | $4.4M |
| Dividend payout ratio | — | — | 339.1% | 71.5% |
| Dividends + buybacks / free cash flow | — | 673.5% | 113.7% | 49.7% |
| Capex / revenue | 10.8% | 0.7% | 3.7% | 1.9% |
| Capex / operating cash flow | — | 8.5% | 7.0% | 4.5% |
| Capex / depreciation | 4.06 | 0.32 | 4.77 | 6.17 |
| Stock-based compensation / revenue | 27.3% | 0.0% | — | — |
| SG&A / revenue | 150.2% | 73.7% | 26.1% | 13.9% |
| Efficiency | ||||
| Days sales outstanding | 31.6 | 98.6 | 148.6 | 125.8 |
| Days of inventory on hand | 20.3 | 12.5 | 4.7 | 2.2 |
| Days payables outstanding | 72.7 | 54.4 | 23.7 | 18.3 |
| Cash conversion cycle (days) | -20.9 | 56.7 | 129.6 | 109.7 |
| Receivables turnover | 11.55 | 3.70 | 2.46 | 2.90 |
| Payables turnover | 5.02 | 6.71 | 15.39 | 19.94 |
| Inventory turnover | 18.02 | 29.29 | 77.80 | 167.61 |
| Asset turnover | 1.05 | 0.89 | 1.06 | 1.49 |
| Average receivables | $495,603 | $1.8M | $5.4M | $7.8M |
| Average payables | $721,028 | $595,996 | $490,788 | $667,625 |
| Average inventory | $200,824 | $136,550 | $97,092 | $79,445 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from CJMB's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CJMB valuation and financial ratios
Callan JMB earned a return on equity of −289.6% and a return on invested capital of −245.3% in fiscal 2025. It ended the year with $2.0 million of debt and $2.1 million in cash and short-term investments, a net cash position of $0.1 million.
See the CJMB income statement, the CJMB chart for price history, or the CJMB stock overview for the latest quote and news.
CJMB key metrics FAQ
What is Callan JMB's return on equity?
Callan JMB's return on equity (ROE) was −289.6% in fiscal 2025: net income of -$8.0 million on average shareholders' equity of $2.8 million.
What is Callan JMB's ROIC?
Callan JMB's return on invested capital was −245.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Callan JMB have?
Callan JMB had total debt of $2.0 million at the end of fiscal 2025, a debt-to-equity ratio of 0.86 and more cash than debt.
Does Callan JMB pay a dividend?
Callan JMB did not pay a dividend in fiscal 2025.
What is Callan JMB's free cash flow yield?
Callan JMB generated -$5.2 million of free cash flow in fiscal 2025, a free cash flow yield of −106.2% on its market value at year-end ($4.9 million).
What is Callan JMB's current ratio?
Callan JMB's current ratio was 2.16 at the end of fiscal 2025: current assets were 2.16 times current liabilities.